Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Who holds Alzamend Neuro, Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 1.3M | +134.5% | $1.6M | 1.3% | Aug 25, 2026 |
| KMT Wealth Management, LLC | 1.3M | New | $1.6M | 1.3% | Aug 5, 2026 |
| Geode Capital Management, LLC | 26.4K | −42.3% | $31.6K | 0% | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 21K | ±0% | $25.2K | 0% | Aug 13, 2026 |
| Vanguard Capital Management LLC | 7.6K | +71.7% | $9.1K | 0% | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 3.5K | −43.1% | $4.2K | 0.1% | Aug 11, 2026 |
| UBS Group AG | 2.4K | −47.8% | $2.8K | 0% | Aug 13, 2026 |
| BlackRock, Inc. | 437 | ±0% | $524 | 0% | Aug 7, 2026 |
| IFG Advisory, LLC | 22 | New | $26 | 0% | Aug 14, 2026 |
| SBI Securities Co., Ltd. | 22 | ±0% | $26 | 0% | Jul 23, 2026 |
| Caitong International Asset Management Co., Ltd | 3 | −25.0% | $4 | 0% | Aug 5, 2026 |
| Harbor Investment Advisory, LLC | 1 | ±0% | $1 | 0% | Jul 7, 2026 |
